VAXART PROVIDES UPDATE ON PROXY VOTING
KUALA LUMPUR, July 28 (Bernama) -- Clinical-stage biotechnology company Vaxart Inc urged its stockholders of record on April 11, 2022, to vote on its proxy if they have not yet done so and encouraged them to vote yes on all Proxy Proposals, including Proxy Proposal #2.
Proposal #2 is an amendment to the Company’s Restated Certificate of Incorporation to increase the authorised number of shares of its common stock to 250 million shares.
“Proposal #2 is important for shareholders and for the company, because it would enable us to continue to work to unlock and create value by investing in the business so that we can progress our programmes,” said Vaxart’s Chief Executive Officer Andrei Floroiu in a statement.
“It would also allow us to maintain a strong balance sheet and remain in a strong competitive position, and it would enable us to continue to attract and retain key talent. We strongly urge shareholders to vote before the Aug 3, 2022, deadline.”
Both leading independent proxy advisory firms, Institutional Shareholder Services (ISS) and Glass Lewis, recommend that shareholders support Proposal #2.
Vaxart’s 2022 Annual Meeting of Stockholders was adjourned to Aug 4.
-- BERNAMA
BERNAMA provides up-to-date authentic and comprehensive news and information which are disseminated via BERNAMA Wires; www.bernama.com; BERNAMA TV on Astro 502, unifi TV 631 and MYTV 121 IFLIX channels and BERNAMA Radio on FM93.9 (Klang Valley), FM107.5 (Johor Bahru), FM107.9 (Kota Kinabalu) and FM100.9 (Kuching) frequencies.
Follow us on social media :
Facebook : @bernamaofficial, @bernamatv, @bernamaradio
Twitter : @bernama.com, @BernamaTV, @bernamaradio
Instagram : @bernamaofficial, @bernamatvofficial, @bernamaradioofficial
TikTok : @bernamaofficial
